
Sign up to save your podcasts
Or


Adam P. Dicker, MD, PhD, of the Thomas Jefferson University Sidney Kimmel Cancer Center, walks us through the debate about the value of local treatment for newly diagnosed metastatic prostate cancer.
By American Society of Clinical Oncology (ASCO)4.6
5656 ratings
Adam P. Dicker, MD, PhD, of the Thomas Jefferson University Sidney Kimmel Cancer Center, walks us through the debate about the value of local treatment for newly diagnosed metastatic prostate cancer.

137 Listeners

320 Listeners

497 Listeners

40 Listeners

3,337 Listeners

124 Listeners

44 Listeners

324 Listeners

31 Listeners

513 Listeners

57 Listeners

34 Listeners

19 Listeners

185 Listeners

43 Listeners